Skip to main content
Earnings Labs
CytomX Therapeutics, Inc. logo

CytomX Therapeutics, Inc. (CTMX)

NASDAQ·Healthcare·Biotechnology

$3.08

+4.95%

Mkt Cap $484.08M

Analyst Ratings

Buy

13

Hold

0

Sell

0

Price Target (21 analysts)

$11.50

Range $10.00$16.00

Implied Upside

+274.0%

Consensus $11.50 vs current $3.08